Researchers outline framework linking chronic crisis stress to accelerated metabolic ageing and sarcopenic obesity

A newly published perspective in Biogerontology outlines a biological framework showing how prolonged crisis-induced chronic stress accelerates metabolic ageing, cellular senescence, and sarcopenic obesity, emphasizing the need for integrated clinical screening in vulnerable older populations.

Researchers from the Kyiv School of Economics, Vasyl Stefanyk Carpathian National University, and other Ukrainian institutions published a perspective article in Biogerontology on September 3, 2026.

The authors present a framework showing how prolonged social, physical, and psychological stressors drive maladaptive biological responses in older adults.

These stress-induced biological pathways include chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis, altered glucocorticoid signaling, cellular senescence, the senescence-associated secretory phenotype (SASP), adipose tissue inflammation, insulin resistance, mitochondrial dysfunction, and anabolic resistance in skeletal muscle.

The paper uses Ukraine's current demographic and conflict situation as a primary case study where war, displacement, and non-communicable diseases intersect.

The research bridges the gap between environmental-societal crises and cellular-level aging mechanisms, offering a physiological explanation for why crisis-exposed populations show rapid metabolic and functional decline.

By identifying specific pathways such as SASP, mitochondrial dysfunction, and skeletal muscle anabolic resistance, the authors define concrete molecular targets that mediate the physical frailty associated with chronic trauma.

The perspective advocates for a clinical shift away from isolated treatment protocols toward integrated screening regimens combining mental health, metabolic, nutritional, and muscle assessments.

The established link between chronic stress and accelerated cellular senescence underscores the potential therapeutic utility of senolytics and SASP-targeting therapeutics in trauma-exposed populations.

Clinical and commercial programs addressing age-related mitochondrial dysfunction and insulin resistance may see an expanded rationale for targeting stress-induced metabolic syndromes.

An increase in structured public health and screening initiatives, such as the referenced 'Health Screening 40+' program, could drive demand for continuous metabolic monitoring and remote health-assessment technologies.

The potential expansion of multi-domain health screening protocols in crisis zones to measure the combined effects of psychological stress and metabolic decline on the functional ability of older adults.